Literature DB >> 22786590

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Manu Sharma1, John P A Ioannidis, Jan O Aasly, Grazia Annesi, Alexis Brice, Christine Van Broeckhoven, Lars Bertram, Maria Bozi, David Crosiers, Carl Clarke, Maurizio Facheris, Matthew Farrer, Gaetan Garraux, Suzana Gispert, Georg Auburger, Carles Vilariño-Güell, Georgios M Hadjigeorgiou, Andrew A Hicks, Nobutaka Hattori, Beom Jeon, Suzanne Lesage, Christina M Lill, Juei-Jueng Lin, Timothy Lynch, Peter Lichtner, Anthony E Lang, Vincent Mok, Barbara Jasinska-Myga, George D Mellick, Karen E Morrison, Grzegorz Opala, Peter P Pramstaller, Irene Pichler, Sung Sup Park, Aldo Quattrone, Ekaterina Rogaeva, Owen A Ross, Leonidas Stefanis, Joanne D Stockton, Wataru Satake, Peter A Silburn, Jessie Theuns, Eng-King Tan, Tatsushi Toda, Hiroyuki Tomiyama, Ryan J Uitti, Karin Wirdefeldt, Zbigniew Wszolek, Georgia Xiromerisiou, Kuo-Chu Yueh, Yi Zhao, Thomas Gasser, Demetrius Maraganore, Rejko Krüger.   

Abstract

OBJECTIVE: Eleven genetic loci have reached genome-wide significance in a recent meta-analysis of genome-wide association studies in Parkinson disease (PD) based on populations of Caucasian descent. The extent to which these genetic effects are consistent across different populations is unknown.
METHODS: Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium were invited to participate in the study. A total of 11 SNPs were genotyped in 8,750 cases and 8,955 controls. Fixed as well as random effects models were used to provide the summary risk estimates for these variants. We evaluated between-study heterogeneity and heterogeneity between populations of different ancestry.
RESULTS: In the overall analysis, single nucleotide polymorphisms (SNPs) in 9 loci showed significant associations with protective per-allele odds ratios of 0.78-0.87 (LAMP3, BST1, and MAPT) and susceptibility per-allele odds ratios of 1.14-1.43 (STK39, GAK, SNCA, LRRK2, SYT11, and HIP1R). For 5 of the 9 replicated SNPs there was nominally significant between-site heterogeneity in the effect sizes (I(2) estimates ranged from 39% to 48%). Subgroup analysis by ethnicity showed significantly stronger effects for the BST1 (rs11724635) in Asian vs Caucasian populations and similar effects for SNCA, LRRK2, LAMP3, HIP1R, and STK39 in Asian and Caucasian populations, while MAPT rs2942168 and SYT11 rs34372695 were monomorphic in the Asian population, highlighting the role of population-specific heterogeneity in PD.
CONCLUSION: Our study allows insight to understand the distribution of newly identified genetic factors contributing to PD and shows that large-scale evaluation in diverse populations is important to understand the role of population-specific heterogeneity.

Entities:  

Mesh:

Year:  2012        PMID: 22786590      PMCID: PMC3414661          DOI: 10.1212/WNL.0b013e318264e353

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  'Racial' differences in genetic effects for complex diseases.

Authors:  John P A Ioannidis; Evangelia E Ntzani; Thomas A Trikalinos
Journal:  Nat Genet       Date:  2004-11-14       Impact factor: 38.330

3.  Aspects of observing and claiming allele flips in association studies.

Authors:  Geraldine M Clarke; Lon R Cardon
Journal:  Genet Epidemiol       Date:  2010-04       Impact factor: 2.135

4.  Genome-wide association study confirms extant PD risk loci among the Dutch.

Authors:  Javier Simón-Sánchez; Jacobus J van Hilten; Bart van de Warrenburg; Bart Post; Henk W Berendse; Sampath Arepalli; Dena G Hernandez; Rob M A de Bie; Daan Velseboer; Hans Scheffer; Bas Bloem; Karin D van Dijk; Fernando Rivadeneira; Albert Hofman; André G Uitterlinden; Patrizia Rizzu; Zoltan Bochdanovits; Andrew B Singleton; Peter Heutink
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 5.  Finding the missing heritability of complex diseases.

Authors:  Teri A Manolio; Francis S Collins; Nancy J Cox; David B Goldstein; Lucia A Hindorff; David J Hunter; Mark I McCarthy; Erin M Ramos; Lon R Cardon; Aravinda Chakravarti; Judy H Cho; Alan E Guttmacher; Augustine Kong; Leonid Kruglyak; Elaine Mardis; Charles N Rotimi; Montgomery Slatkin; David Valle; Alice S Whittemore; Michael Boehnke; Andrew G Clark; Evan E Eichler; Greg Gibson; Jonathan L Haines; Trudy F C Mackay; Steven A McCarroll; Peter M Visscher
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

6.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.

Authors:  Wataru Satake; Yuko Nakabayashi; Ikuko Mizuta; Yushi Hirota; Chiyomi Ito; Michiaki Kubo; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Masahiko Watanabe; Atsushi Takeda; Hiroyuki Tomiyama; Kenji Nakashima; Kazuko Hasegawa; Fumiya Obata; Takeo Yoshikawa; Hideshi Kawakami; Saburo Sakoda; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Yusuke Nakamura; Tatsushi Toda
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

7.  Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.

Authors:  Chris C A Spencer; Vincent Plagnol; Amy Strange; Michelle Gardner; Coro Paisan-Ruiz; Gavin Band; Roger A Barker; Celine Bellenguez; Kailash Bhatia; Hannah Blackburn; Jennie M Blackwell; Elvira Bramon; Martin A Brown; Matthew A Brown; David Burn; Juan-Pablo Casas; Patrick F Chinnery; Carl E Clarke; Aiden Corvin; Nicholas Craddock; Panos Deloukas; Sarah Edkins; Jonathan Evans; Colin Freeman; Emma Gray; John Hardy; Gavin Hudson; Sarah Hunt; Janusz Jankowski; Cordelia Langford; Andrew J Lees; Hugh S Markus; Christopher G Mathew; Mark I McCarthy; Karen E Morrison; Colin N A Palmer; Justin P Pearson; Leena Peltonen; Matti Pirinen; Robert Plomin; Simon Potter; Anna Rautanen; Stephen J Sawcer; Zhan Su; Richard C Trembath; Ananth C Viswanathan; Nigel W Williams; Huw R Morris; Peter Donnelly; Nicholas W Wood
Journal:  Hum Mol Genet       Date:  2010-11-02       Impact factor: 6.150

8.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

9.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Authors:  Nathan Pankratz; Jemma B Wilk; Jeanne C Latourelle; Anita L DeStefano; Cheryl Halter; Elizabeth W Pugh; Kimberly F Doheny; James F Gusella; William C Nichols; Tatiana Foroud; Richard H Myers
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

10.  Evolutionary toggling of the MAPT 17q21.31 inversion region.

Authors:  Michael C Zody; Zhaoshi Jiang; Hon-Chung Fung; Francesca Antonacci; LaDeana W Hillier; Maria Francesca Cardone; Tina A Graves; Jeffrey M Kidd; Ze Cheng; Amr Abouelleil; Lin Chen; John Wallis; Jarret Glasscock; Richard K Wilson; Amy Denise Reily; Jaime Duckworth; Mario Ventura; John Hardy; Wesley C Warren; Evan E Eichler
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

View more
  56 in total

1.  Association between Parkinson's disease and G2019S and R1441C mutations of the LRRK2 gene.

Authors:  Xiao-Xia Li; Qin Liao; Huan Xia; Xin-Ling Yang
Journal:  Exp Ther Med       Date:  2015-07-27       Impact factor: 2.447

2.  LRRK2 secretion in exosomes is regulated by 14-3-3.

Authors:  Kyle B Fraser; Mark S Moehle; João P L Daher; Philip J Webber; Jeri Y Williams; Carrie A Stewart; Talene A Yacoubian; Rita M Cowell; Terje Dokland; Tong Ye; Dongquan Chen; Gene P Siegal; Robert A Galemmo; Elpida Tsika; Darren J Moore; David G Standaert; Kyoko Kojima; James A Mobley; Andrew B West
Journal:  Hum Mol Genet       Date:  2013-07-25       Impact factor: 6.150

3.  Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson's disease revealed different epigenetic patterns in peripheral blood mononuclear cells.

Authors:  Oliver Kaut; Ina Schmitt; Jörg Tost; Florence Busato; Yi Liu; Per Hofmann; Stephanie H Witt; Marcella Rietschel; Holger Fröhlich; Ullrich Wüllner
Journal:  Neurogenetics       Date:  2016-10-06       Impact factor: 2.660

4.  Transcriptome study of differential expression in schizophrenia.

Authors:  Alan R Sanders; Harald H H Göring; Jubao Duan; Eugene I Drigalenko; Winton Moy; Jessica Freda; Deli He; Jianxin Shi; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2013-07-30       Impact factor: 6.150

5.  GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16.

Authors:  Alexandra I Soto-Ortolaza; Michael G Heckman; Catherine Labbé; Daniel J Serie; Andreas Puschmann; Sruti Rayaprolu; Audrey Strongosky; Magdalena Boczarska-Jedynak; Grzegorz Opala; Anna Krygowska-Wajs; Maria Barcikowska; Krzysztof Czyzewski; Timothy Lynch; Ryan J Uitti; Zbigniew K Wszolek; Owen A Ross
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

6.  α-Synuclein oligomers impair neuronal microtubule-kinesin interplay.

Authors:  Iryna Prots; Vanesa Veber; Stefanie Brey; Silvia Campioni; Katrin Buder; Roland Riek; Konrad J Böhm; Beate Winner
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

7.  Widespread Tau-Specific CD4 T Cell Reactivity in the General Population.

Authors:  Cecilia S Lindestam Arlehamn; John Pham; Roy N Alcalay; April Frazier; Evan Shorr; Chelsea Carpenter; John Sidney; Rekha Dhanwani; Julian Agin-Liebes; Francesca Garretti; Amy W Amara; David G Standaert; Elizabeth J Phillips; Simon A Mallal; Bjoern Peters; David Sulzer; Alessandro Sette
Journal:  J Immunol       Date:  2019-05-13       Impact factor: 5.422

Review 8.  Genes associated with Parkinson's disease: regulation of autophagy and beyond.

Authors:  Alexandra Beilina; Mark R Cookson
Journal:  J Neurochem       Date:  2015-09-03       Impact factor: 5.372

9.  Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.

Authors:  Catherine Labbé; Kotaro Ogaki; Oswaldo Lorenzo-Betancor; Alexandra I Soto-Ortolaza; Ronald L Walton; Sruti Rayaprolu; Shinsuke Fujioka; Melissa E Murray; Michael G Heckman; Andreas Puschmann; Allan McCarthy; Timothy Lynch; Joanna Siuda; Grzegorz Opala; Monika Rudzinska; Anna Krygowska-Wajs; Maria Barcikowska; Krzysztof Czyzewski; Yanosh Sanotsky; Irena Rektorová; Pamela J McLean; Rosa Rademakers; Nilüfer Ertekin-Taner; Anhar Hassan; J Eric Ahlskog; Bradley F Boeve; Ronald C Petersen; Demetrius M Maraganore; Charles H Adler; Tanis J Ferman; Joseph E Parisi; Neill R Graff-Radford; Ryan J Uitti; Zbigniew K Wszolek; Dennis W Dickson; Owen A Ross
Journal:  Neurology       Date:  2015-09-02       Impact factor: 9.910

10.  Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's Disease.

Authors:  Xin Wang; Nuomin Li; Nian Xiong; Qi You; Jie Li; Jinlong Yu; Hong Qing; Tao Wang; Heather J Cordell; Ole Isacson; Jeffery M Vance; Eden R Martin; Ying Zhao; Bruce M Cohen; Edgar A Buttner; Zhicheng Lin
Journal:  Mol Neurobiol       Date:  2016-03-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.